Jupiter Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Jupiter Asset Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$110M	Sell	218,925 -15,095	-6%	-$7.25M	0.55%	45
2026 Q1	$111M	Buy	+234,020	New	+$127M	0.59%	42
2025 Q2	–	Sell	-2,586	Closed	-$1.29M	–	516
2025 Q1	$1.29M	Buy	+2,586	New	+$1.4M	0.01%	359
2024 Q2	–	Sell	-44,019	Closed	-$25.6M	–	462
2024 Q1	$25.6M	Buy	44,019 +31	+0.1%	+$17.4K	0.24%	144
2023 Q4	$23.3M	Sell	43,988 -45	-0.1%	-$21.8K	0.23%	142
2023 Q3	$22.3M	Hold	44,033	–	–	0.25%	126
2023 Q2	$23M	Sell	44,033 -39,497	-47%	-$21.3M	0.25%	124
2023 Q1	$48.1M	Sell	83,530 -21,735	-21%	-$12.3M	0.66%	30
2022 Q4	$58M	Sell	105,265 -78,787	-43%	-$41.7M	0.85%	19
2022 Q3	$93.3M	Sell	184,052 -15,506	-8%	-$8.68M	1.44%	10
2022 Q2	$109M	Sell	199,558 -986	-0.5%	-$543K	1.53%	8
2022 Q1	$119M	Buy	200,544 +40,274	+25%	+$23.1M	1.41%	7
2021 Q4	$107M	Buy	160,270 +5,355	+3%	+$3.34M	1.17%	10
2021 Q3	$88.5M	Sell	154,915 -58,073	-27%	-$31.9M	1%	13
2021 Q2	$107M	Buy	212,988 +45,100	+27%	+$21.3M	1.11%	13
2021 Q1	$76.7M	Sell	167,888 -18,310	-10%	-$8.74M	0.75%	19
2020 Q4	$86.7M	Buy	186,198 +29,411	+19%	+$13.8M	0.87%	15
2020 Q3	$69.1M	Buy	+156,787	New	+$64.8M	0.73%	24
2019 Q2	–	Sell	-2,710	Closed	-$741K	–	236
2019 Q1	$741K	Buy	2,710 +1,787	+194%	+$445K	0.02%	201
2018 Q4	$207K	Buy	+923	New	+$217K	0.01%	225

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Jupiter Asset Management's TMO Position: Q2 2026 in Review

Jupiter Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 6.5% in Q2 2026, selling an estimated $7.25M and leaving 218,925 shares worth $110M. The position accounts for 0.55% of the portfolio, ranked #45.

Jupiter Asset Management first reported a position in TMO in Q4 2018 and has held it in 20 quarters since. The position peaked at $119M in Q1 2022. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Jupiter Asset Management held 218,925 shares of Thermo Fisher Scientific worth $110M as of Q2 2026.
Jupiter Asset Management sold 15,095 Thermo Fisher Scientific shares in Q2 2026, an estimated $7.25M.
Thermo Fisher Scientific made up 0.55% of Jupiter Asset Management's portfolio in Q2 2026, its #45 holding.
Jupiter Asset Management first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 20 quarters since.
Jupiter Asset Management's Thermo Fisher Scientific position peaked at $119M in Q1 2022.
2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Jupiter Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.